No Data
Barclays Remains a Buy on Eli Lilly & Co (LLY)
Eli Lilly +5%, Named 'Top Pick' Following Q2 Beat Morgan Stanley Says
What Eli Lilly, Novo Nordisk Earnings Reveal About the Future of GLP-1 Sales
About 73% of the S&P 500 Names Beat on EPS During the Week - Earnings Scorecard
Why Are Hedge Funds Bullish on Eli Lilly and Company (LLY) Now?
Eli Lilly and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Laine Ford : that what up in the stock would